Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Nov 22:10:1019332.
doi: 10.3389/fchem.2022.1019332. eCollection 2022.

Fabrication of gentamicin loaded Col-I/HA multilayers modified titanium coatings for prevention of implant infection

Affiliations

Fabrication of gentamicin loaded Col-I/HA multilayers modified titanium coatings for prevention of implant infection

Le Ma et al. Front Chem. .

Abstract

In this study, gentamicin loaded collagen I/hyaluronic acid multilayers modified titanium coating (TC-AA(C/H)6-G) was fabricated via a layer-by-layer (LBL) covalent immobilization method. The drug releasing properties of collagen I/Hyaluronic acid (Col-I/HA) multilayers and the effect of loaded gentamicin on the antibacterial properties and cytocompatibility of modified TC were investigated. The gentamicin release assay indicated that the Col-I/HA multilayers modified TC exhibited agreeable drug-loading amount (537.22 ± 29.66 µg of gentamicin) and controlled-release performance (240 h of sustained release time). TC-AA(C/H)6-G revealed satisfactory antibacterial activity and inhibited the colonization and biofilm formation of S. aureus. Fortunately, the functions of hMSCs on TC-AA(C/H)6-G did not affected by the loaded gentamicin, and TC-AA(C/H)6-G could improve the adhesion, proliferation and osteogenic differentiation of cells, as well as TC-AA(C/H)6. In vivo animal study indicated that TC-AA(C/H)6-G could effectively control intramedullary cavity infection caused by S. aureus and prevent bone destruction.

Keywords: Col-I/HA multilayers; cytocompatibility; drug-release; prevention infection; titanium coatings.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
Schematic illustration of the fabrication of gentamicin loaded Col-I/HA multilayers on titanium coating via a LBL covalent immobilization technique.
FIGURE 2
FIGURE 2
SEM of samples (A), Drug loaded amount (B) and cumulative release curves of gentamicin (C) of TC-A-G, TC-AAC-G and TC-AA(C/H)6-G.
FIGURE 3
FIGURE 3
The zone of inhibition (ZOI) of multilayer membrane modified TCs loading gentamycin. (A) The ZOI against S. aureus produced by different specimens at different time points; (B) The ZOI diameters of all specimens.
FIGURE 4
FIGURE 4
Antibacterial properties of TC-AA(C/H)6-G. (A) Bacterial colonization and biofilm formation by the spread plate method; (B) SEM of bacteria on the three different specimens after incubated 6 h and 24 h; (C) The CLSM views of bacterial colonization and biofilm formation on the three kinds of samples, green for living bacteria and red for dead bacteria.
FIGURE 5
FIGURE 5
Cytocompatibility of TC, TC-AA(C/H)6 and TC-AA(C/H)6-G. (A) Attachment of hMSCs on three different samples; (B) Proliferation of hMSCs on three different samples; (C) ALP activity was measured using the pNPP assay and normalized based on the protein content per specimen at days 4, 7 and 14; (D) Colorimetric quantitative analysis of the extracellular matrix mineralization on the samples after 21 days of incubation; (E) ALP staining was performed at day 14; (F) Alizarin red staining. *p < 0.05, there has significant difference between TC-AA(C/H)6-G and TC. #p > 0.05, there has no significant difference between TC-AA(C/H)6-G and TC-AA(C/H)6.
FIGURE 6
FIGURE 6
Postoperative changes in temperature (A) and weight (B) of animals.
FIGURE 7
FIGURE 7
-Gross appearance and scores of longitudinal sections of three kinds of femurs. (A) TC and TC-AA(C/H)6 groups showed signs of purulent infections, while the TC-AA(C/H)6-G group showed no obvious infection signs; (B) The score of the TC-AA(C/H)6-G group was significantly lower than other two groups, *p < 0.05.
FIGURE 8
FIGURE 8
Quantification of bacteria obtained from explanted implants and bone tissue on day of sacrifice. (A) Growth of bacterial colonies of implants on TSA; (B) The number of CFU per implant; (C) Amount of CFU per gram of bone. *p < 0.05 compared with TC-AA(C/H)6-G and other two groups.
FIGURE 9
FIGURE 9
(A) X-ray photograph of left femur in lateral view 1 day, 3 and 6 weeks after operation. Typical signs include osteolytic lesions (black arrowhead) and periosteal new bone formation (white arrowhead); (B) 3D images of overall, longitudinal and transverse sections; (C) Quantitative analysis of the X-ray images; (D) the cortical one mineral density (BMD) of ROI; (E) bone volume/total volume (BV/TV) of ROI. *p < 0.05 compared with TC-AA(C/H)6-G and other two groups.
FIGURE 10
FIGURE 10
Representative photomicrographs of longitudinal sections of femurs. (A) H&E staining; (B) Giemsa staining.

Similar articles

Cited by

References

    1. Ao H., Xie Y., Tan H., Yang S., Li K., Wu X., et al. (2013). Fabrication and in vitro evaluation of stable collagen/hyaluronic acid biomimetic multilayer on titanium coatings. J. R. Soc. Interface 10, 20130070. 10.1098/rsif.2013.0070 - DOI - PMC - PubMed
    1. Ao H., Xie Y., Tan H., Wu X., Liu G., Qin A., et al. (2014). Improved hMSC functions on titanium coatings by type I collagen immobilization. J. Biomed. Mater. Res. A 102, 204–214. 10.1002/jbm.a.34682 - DOI - PubMed
    1. Ao H., Yang S., Nie B. e., Fan Q., Zhang Q., Zong J., et al. (2019). Improved antibacterial properties of collagen I/hyaluronic acid/quaternized chitosan multilayer modified titanium coatings with both contact-killing and release-killing functions. J. Mater. Chem. B 7, 1951–1961. 10.1039/c8tb02425a - DOI - PubMed
    1. Bai J., Wang H., Chen H., Ge G., Wang M., Gao A., et al. (2020). Biomimetic osteogenic peptide with mussel adhesion and osteoimmunomodulatory functions to ameliorate interfacial osseointegration under chronic inflammation. Biomaterials 255, 120197. 10.1016/j.biomaterials.2020.120197 - DOI - PubMed
    1. Bayer I. S. (2020). Hyaluronic acid and controlled release: A review. Molecules 25, 2649. 10.3390/molecules25112649 - DOI - PMC - PubMed

LinkOut - more resources